Open-Label Extension Study of Setmelanotide
Public ClinicalTrials.gov record NCT06596135. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Open-Label Extension Study of Setmelanotide in Patients With a Rare Genetic, Syndromic or Acquired Disease of the MC4R Pathway
Study identification
- NCT ID
- NCT06596135
- Recruitment status
- Enrolling by invitation
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Rhythm Pharmaceuticals, Inc.
- Industry
- Enrollment
- 30 participants
Conditions and interventions
Interventions
- Setmelanotide Drug
Drug
Eligibility (public fields only)
- Age range
- 2 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 20, 2024
- Primary completion
- Oct 29, 2027
- Completion
- Oct 29, 2027
- Last update posted
- Sep 3, 2025
2024 – 2027
United States locations
- U.S. sites
- 13
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| HonorHealth Research Institute | Scottsdale | Arizona | 85258 | — |
| UC San Diego- Rady Children's Hospital | San Diego | California | 92123 | — |
| University of Florida at Gainesville | Gainesville | Florida | 32611 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| Mayo Clinic - Rochester | Rochester | Minnesota | 55905 | — |
| Children's Minnesota | Saint Paul | Minnesota | 55102 | — |
| University of Buffalo | Getzville | New York | 14068 | — |
| M3 Wake Research, Inc | Raleigh | North Carolina | 27612 | — |
| Geisinger Health System | Danville | Pennsylvania | 17821 | — |
| WR-ClinSearch | Chattanooga | Tennessee | 37421 | — |
| Vanderbilt University School of Medicine | Nashville | Tennessee | 37232 | — |
| Seattle Children's Research Institute | Seattle | Washington | 98105 | — |
| Marshfield Clinical Research Institute | Marshfield | Wisconsin | 54449 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06596135, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 3, 2025 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06596135 live on ClinicalTrials.gov.